Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myeloproliferative Disorders | 17 | 2024 | 610 | 5.580 |
Why?
|
Dendritic Cells | 28 | 2024 | 2726 | 4.370 |
Why?
|
Hematologic Neoplasms | 20 | 2024 | 1890 | 3.990 |
Why?
|
Interleukin-3 Receptor alpha Subunit | 11 | 2024 | 36 | 2.720 |
Why?
|
Leukemia, Myeloid, Acute | 16 | 2024 | 3610 | 2.370 |
Why?
|
Skin Neoplasms | 16 | 2024 | 5815 | 2.030 |
Why?
|
HMGN1 Protein | 3 | 2020 | 27 | 1.280 |
Why?
|
Recombinant Fusion Proteins | 8 | 2024 | 3734 | 1.220 |
Why?
|
Sulfonamides | 6 | 2024 | 1972 | 1.030 |
Why?
|
Class Ib Phosphatidylinositol 3-Kinase | 1 | 2024 | 43 | 0.910 |
Why?
|
Myelodysplastic Syndromes | 2 | 2024 | 1393 | 0.880 |
Why?
|
p21-Activated Kinases | 1 | 2024 | 128 | 0.880 |
Why?
|
AMP-Activated Protein Kinases | 2 | 2023 | 597 | 0.860 |
Why?
|
Leukemia, Promyelocytic, Acute | 8 | 2019 | 251 | 0.830 |
Why?
|
Hypereosinophilic Syndrome | 1 | 2023 | 97 | 0.820 |
Why?
|
Histiocytic Sarcoma | 1 | 2022 | 40 | 0.790 |
Why?
|
Dioxygenases | 1 | 2024 | 345 | 0.780 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 5 | 2024 | 1404 | 0.770 |
Why?
|
Polycythemia Vera | 1 | 2022 | 160 | 0.720 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2023 | 2821 | 0.680 |
Why?
|
Lymphoma, Follicular | 2 | 2022 | 457 | 0.660 |
Why?
|
Ribonucleoproteins | 1 | 2021 | 372 | 0.640 |
Why?
|
Ultraviolet Rays | 1 | 2023 | 1079 | 0.610 |
Why?
|
Leukemia | 2 | 2024 | 1522 | 0.590 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 1 | 2020 | 212 | 0.590 |
Why?
|
Trisomy | 1 | 2018 | 260 | 0.580 |
Why?
|
Neoplasm Proteins | 8 | 2019 | 3611 | 0.560 |
Why?
|
Mutation | 17 | 2024 | 30025 | 0.550 |
Why?
|
Genes, X-Linked | 1 | 2016 | 128 | 0.530 |
Why?
|
Cyclophosphamide | 3 | 2015 | 2218 | 0.530 |
Why?
|
Leukocyte Elastase | 3 | 2010 | 114 | 0.530 |
Why?
|
Hematopoietic Stem Cell Transplantation | 7 | 2022 | 5663 | 0.520 |
Why?
|
Oncogene Proteins, Fusion | 9 | 2023 | 1604 | 0.520 |
Why?
|
GTP-Binding Protein beta Subunits | 1 | 2014 | 33 | 0.490 |
Why?
|
Down Syndrome | 2 | 2023 | 897 | 0.480 |
Why?
|
Chromosomes, Human, X | 1 | 2016 | 321 | 0.480 |
Why?
|
Myeloablative Agonists | 2 | 2015 | 209 | 0.470 |
Why?
|
X Chromosome Inactivation | 1 | 2016 | 227 | 0.470 |
Why?
|
Lysine | 2 | 2018 | 993 | 0.450 |
Why?
|
Carmustine | 2 | 2015 | 138 | 0.430 |
Why?
|
Gene Duplication | 1 | 2014 | 313 | 0.420 |
Why?
|
Xenograft Model Antitumor Assays | 6 | 2024 | 3592 | 0.420 |
Why?
|
Rare Diseases | 1 | 2017 | 621 | 0.400 |
Why?
|
Genes, Tumor Suppressor | 1 | 2016 | 1062 | 0.400 |
Why?
|
Histones | 4 | 2020 | 2579 | 0.400 |
Why?
|
Proto-Oncogene Proteins | 1 | 2024 | 4511 | 0.390 |
Why?
|
Busulfan | 2 | 2015 | 258 | 0.380 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 7 | 2020 | 11729 | 0.380 |
Why?
|
Etoposide | 2 | 2015 | 634 | 0.380 |
Why?
|
Acute Disease | 6 | 2024 | 7230 | 0.380 |
Why?
|
Transplantation Conditioning | 3 | 2015 | 1588 | 0.370 |
Why?
|
Anemia, Aplastic | 1 | 2013 | 228 | 0.370 |
Why?
|
Humans | 76 | 2024 | 760239 | 0.360 |
Why?
|
GTP-Binding Proteins | 1 | 2014 | 950 | 0.350 |
Why?
|
von Willebrand Disease, Type 2 | 1 | 2010 | 7 | 0.350 |
Why?
|
Azacitidine | 2 | 2024 | 336 | 0.350 |
Why?
|
Acetylation | 3 | 2020 | 1057 | 0.340 |
Why?
|
Hematopoietic Stem Cells | 2 | 2020 | 3395 | 0.340 |
Why?
|
Skin | 1 | 2023 | 4474 | 0.330 |
Why?
|
Neoplasms | 7 | 2024 | 22077 | 0.320 |
Why?
|
Clone Cells | 2 | 2023 | 1660 | 0.300 |
Why?
|
Drug Delivery Systems | 1 | 2019 | 2224 | 0.300 |
Why?
|
Chromatin | 1 | 2020 | 2951 | 0.300 |
Why?
|
Lymphoma, B-Cell | 1 | 2014 | 940 | 0.300 |
Why?
|
Disease Management | 4 | 2024 | 2500 | 0.290 |
Why?
|
Hodgkin Disease | 2 | 2015 | 1378 | 0.290 |
Why?
|
Drug Resistance, Neoplasm | 5 | 2021 | 5291 | 0.280 |
Why?
|
DNA-Binding Proteins | 1 | 2024 | 9590 | 0.280 |
Why?
|
Lymphoma | 2 | 2016 | 1901 | 0.270 |
Why?
|
Janus Kinase 2 | 3 | 2015 | 544 | 0.270 |
Why?
|
Antineoplastic Agents | 10 | 2022 | 13618 | 0.270 |
Why?
|
Cell Line, Tumor | 10 | 2022 | 16948 | 0.270 |
Why?
|
Mice | 24 | 2024 | 81406 | 0.260 |
Why?
|
B-Lymphocytes | 2 | 2018 | 4747 | 0.240 |
Why?
|
Oxidative Phosphorylation | 2 | 2024 | 497 | 0.240 |
Why?
|
Disease Susceptibility | 3 | 2020 | 1789 | 0.240 |
Why?
|
Transcription, Genetic | 1 | 2018 | 7595 | 0.240 |
Why?
|
Animals | 30 | 2024 | 168245 | 0.240 |
Why?
|
Stem Cell Transplantation | 2 | 2019 | 1598 | 0.240 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2009 | 775 | 0.230 |
Why?
|
Receptors, Retinoic Acid | 1 | 2005 | 224 | 0.230 |
Why?
|
Cytarabine | 2 | 2024 | 697 | 0.230 |
Why?
|
U937 Cells | 5 | 2022 | 262 | 0.220 |
Why?
|
T-Lymphocytes | 5 | 2023 | 10188 | 0.220 |
Why?
|
Signal Transduction | 5 | 2024 | 23405 | 0.220 |
Why?
|
Bone Marrow | 5 | 2024 | 2907 | 0.210 |
Why?
|
Nucleosomes | 2 | 2018 | 484 | 0.210 |
Why?
|
Molecular Targeted Therapy | 5 | 2020 | 2804 | 0.210 |
Why?
|
Sunlight | 1 | 2024 | 336 | 0.200 |
Why?
|
Fusion Proteins, bcr-abl | 2 | 2014 | 431 | 0.200 |
Why?
|
Histiocytes | 1 | 2022 | 98 | 0.200 |
Why?
|
Gene Expression Regulation, Leukemic | 2 | 2021 | 651 | 0.190 |
Why?
|
eIF-2 Kinase | 1 | 2022 | 145 | 0.190 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2023 | 1549 | 0.180 |
Why?
|
Aged | 15 | 2024 | 168773 | 0.180 |
Why?
|
DEAD-box RNA Helicases | 1 | 2023 | 383 | 0.180 |
Why?
|
Pneumonia | 1 | 2012 | 2140 | 0.170 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2022 | 220 | 0.170 |
Why?
|
Protein Kinase Inhibitors | 4 | 2020 | 5662 | 0.170 |
Why?
|
Unfolded Protein Response | 1 | 2022 | 234 | 0.170 |
Why?
|
Hepatitis C | 1 | 2010 | 1583 | 0.170 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2023 | 2510 | 0.170 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2021 | 381 | 0.170 |
Why?
|
Liver Cirrhosis | 1 | 2010 | 1934 | 0.170 |
Why?
|
North America | 1 | 2023 | 1274 | 0.160 |
Why?
|
Pyrimidinones | 1 | 2022 | 384 | 0.160 |
Why?
|
Standard of Care | 1 | 2023 | 550 | 0.160 |
Why?
|
ras Proteins | 1 | 2024 | 1052 | 0.160 |
Why?
|
Syringes | 1 | 2019 | 57 | 0.160 |
Why?
|
Cell Line | 4 | 2024 | 15602 | 0.160 |
Why?
|
Mycoses | 1 | 2022 | 386 | 0.160 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2019 | 293 | 0.160 |
Why?
|
Plasmacytoma | 1 | 2019 | 171 | 0.160 |
Why?
|
Transplantation, Autologous | 3 | 2015 | 2113 | 0.160 |
Why?
|
Adult | 20 | 2024 | 220718 | 0.150 |
Why?
|
Cell Survival | 2 | 2020 | 5785 | 0.150 |
Why?
|
Organ Specificity | 1 | 2023 | 1956 | 0.150 |
Why?
|
Neoplasms, Second Primary | 2 | 2020 | 1051 | 0.150 |
Why?
|
Aged, 80 and over | 8 | 2024 | 58838 | 0.150 |
Why?
|
Tretinoin | 3 | 2019 | 519 | 0.150 |
Why?
|
Galectins | 1 | 2021 | 295 | 0.150 |
Why?
|
Bone Marrow Cells | 2 | 2023 | 2415 | 0.150 |
Why?
|
HSP90 Heat-Shock Proteins | 2 | 2012 | 425 | 0.150 |
Why?
|
Cell Proliferation | 6 | 2016 | 10430 | 0.150 |
Why?
|
Prognosis | 6 | 2024 | 29547 | 0.150 |
Why?
|
Cell Death | 1 | 2023 | 1665 | 0.150 |
Why?
|
Male | 24 | 2024 | 359943 | 0.150 |
Why?
|
Immune Evasion | 1 | 2021 | 363 | 0.150 |
Why?
|
Thyroglobulin | 1 | 2017 | 111 | 0.140 |
Why?
|
Single-Cell Analysis | 4 | 2022 | 2414 | 0.140 |
Why?
|
Female | 28 | 2024 | 391766 | 0.140 |
Why?
|
Milk Proteins | 1 | 2017 | 163 | 0.140 |
Why?
|
Frail Elderly | 1 | 2022 | 759 | 0.140 |
Why?
|
DNA, Mitochondrial | 1 | 2022 | 869 | 0.140 |
Why?
|
Phosphorylation | 4 | 2024 | 8313 | 0.130 |
Why?
|
Hashimoto Disease | 1 | 2017 | 105 | 0.130 |
Why?
|
Immunoconjugates | 1 | 2024 | 953 | 0.130 |
Why?
|
Cell Lineage | 2 | 2023 | 2539 | 0.130 |
Why?
|
Leukemia, Myeloid | 1 | 2019 | 694 | 0.130 |
Why?
|
Mitochondria | 3 | 2024 | 3625 | 0.130 |
Why?
|
Child | 9 | 2024 | 80070 | 0.130 |
Why?
|
Imidazoles | 1 | 2022 | 1180 | 0.130 |
Why?
|
Gender Identity | 1 | 2021 | 765 | 0.130 |
Why?
|
Antigens, Neoplasm | 1 | 2023 | 1994 | 0.130 |
Why?
|
Tissue Banks | 1 | 2016 | 184 | 0.120 |
Why?
|
Interleukin-2 | 1 | 2022 | 1891 | 0.120 |
Why?
|
K562 Cells | 3 | 2010 | 643 | 0.120 |
Why?
|
Fluid Therapy | 1 | 2019 | 579 | 0.120 |
Why?
|
DNA Methylation | 3 | 2019 | 4384 | 0.120 |
Why?
|
Mice, Inbred C57BL | 7 | 2019 | 22127 | 0.120 |
Why?
|
Apoptosis | 4 | 2022 | 9469 | 0.120 |
Why?
|
Multicenter Studies as Topic | 1 | 2019 | 1703 | 0.110 |
Why?
|
Immunoblastic Lymphadenopathy | 1 | 2013 | 40 | 0.110 |
Why?
|
Immunotherapy, Adoptive | 1 | 2023 | 1463 | 0.110 |
Why?
|
Puberty, Precocious | 1 | 2015 | 164 | 0.110 |
Why?
|
Central Nervous System Neoplasms | 1 | 2022 | 916 | 0.110 |
Why?
|
Chromosomes, Human, Pair 21 | 1 | 2014 | 228 | 0.110 |
Why?
|
Menstruation | 1 | 2015 | 307 | 0.110 |
Why?
|
Survival Analysis | 3 | 2016 | 10074 | 0.110 |
Why?
|
Mice, Nude | 1 | 2019 | 3603 | 0.110 |
Why?
|
Neoplastic Stem Cells | 1 | 2021 | 1347 | 0.110 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2019 | 929 | 0.110 |
Why?
|
HL-60 Cells | 2 | 2022 | 363 | 0.100 |
Why?
|
Benchmarking | 1 | 2019 | 1044 | 0.100 |
Why?
|
Treatment Outcome | 5 | 2024 | 64583 | 0.100 |
Why?
|
Menarche | 1 | 2015 | 531 | 0.100 |
Why?
|
Niacinamide | 1 | 2014 | 413 | 0.100 |
Why?
|
Shock, Septic | 1 | 2019 | 764 | 0.100 |
Why?
|
Middle Aged | 13 | 2024 | 220307 | 0.100 |
Why?
|
Resorcinols | 1 | 2012 | 41 | 0.100 |
Why?
|
RNA | 2 | 2019 | 2720 | 0.100 |
Why?
|
Mutagenesis, Insertional | 1 | 2014 | 656 | 0.100 |
Why?
|
Leukemia, B-Cell | 1 | 2012 | 84 | 0.100 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2020 | 8522 | 0.100 |
Why?
|
Infection Control | 1 | 2019 | 985 | 0.090 |
Why?
|
Aminopyridines | 1 | 2015 | 570 | 0.090 |
Why?
|
Phenotype | 4 | 2018 | 16588 | 0.090 |
Why?
|
Young Adult | 9 | 2022 | 59054 | 0.090 |
Why?
|
Methylation | 1 | 2014 | 1082 | 0.090 |
Why?
|
Phenylurea Compounds | 1 | 2014 | 528 | 0.090 |
Why?
|
Lymphoma, T-Cell | 1 | 2013 | 304 | 0.090 |
Why?
|
Radiation, Ionizing | 1 | 2012 | 251 | 0.090 |
Why?
|
Gene Expression | 2 | 2022 | 7586 | 0.090 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2014 | 495 | 0.090 |
Why?
|
Mediastinum | 1 | 2012 | 267 | 0.090 |
Why?
|
Genome | 1 | 2018 | 1739 | 0.090 |
Why?
|
Isoxazoles | 1 | 2012 | 231 | 0.090 |
Why?
|
Benzimidazoles | 1 | 2015 | 855 | 0.090 |
Why?
|
Gene Library | 1 | 2012 | 1059 | 0.090 |
Why?
|
Up-Regulation | 1 | 2018 | 4115 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2022 | 3632 | 0.080 |
Why?
|
Tumor Suppressor Proteins | 1 | 2019 | 2806 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2014 | 2455 | 0.080 |
Why?
|
Membrane Transport Proteins | 1 | 2014 | 1035 | 0.080 |
Why?
|
Models, Genetic | 1 | 2018 | 3446 | 0.080 |
Why?
|
Multiprotein Complexes | 1 | 2014 | 1119 | 0.080 |
Why?
|
Immunotherapy | 1 | 2023 | 4649 | 0.070 |
Why?
|
Dexamethasone | 1 | 2015 | 1944 | 0.070 |
Why?
|
Monocytes | 1 | 2017 | 2573 | 0.070 |
Why?
|
Cell Differentiation | 3 | 2020 | 11527 | 0.070 |
Why?
|
Internet | 2 | 2016 | 3090 | 0.070 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2015 | 1373 | 0.070 |
Why?
|
Genomics | 1 | 2023 | 5807 | 0.070 |
Why?
|
Mice, Inbred C3H | 2 | 2005 | 915 | 0.070 |
Why?
|
Oncogenes | 1 | 2012 | 1223 | 0.070 |
Why?
|
Epigenesis, Genetic | 1 | 2020 | 3783 | 0.070 |
Why?
|
Prevalence | 1 | 2023 | 15689 | 0.070 |
Why?
|
Clinical Trials as Topic | 1 | 2022 | 7995 | 0.070 |
Why?
|
Bone Marrow Transplantation | 1 | 2014 | 2692 | 0.070 |
Why?
|
Genetic Predisposition to Disease | 4 | 2020 | 17859 | 0.060 |
Why?
|
Adolescent | 7 | 2022 | 88173 | 0.060 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2014 | 2058 | 0.060 |
Why?
|
Histone Deacetylases | 1 | 2009 | 719 | 0.060 |
Why?
|
Penetrance | 2 | 2004 | 388 | 0.060 |
Why?
|
Combined Modality Therapy | 2 | 2019 | 8522 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2019 | 10758 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9265 | 0.060 |
Why?
|
Vaccines, DNA | 1 | 2005 | 286 | 0.060 |
Why?
|
In Situ Nick-End Labeling | 1 | 2005 | 609 | 0.060 |
Why?
|
Pediatrics | 1 | 2019 | 3593 | 0.060 |
Why?
|
Molecular Weight | 2 | 2003 | 2186 | 0.050 |
Why?
|
Cell Extracts | 1 | 2003 | 135 | 0.050 |
Why?
|
SOXC Transcription Factors | 1 | 2023 | 41 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2014 | 4570 | 0.050 |
Why?
|
Promoter Regions, Genetic | 1 | 2014 | 5782 | 0.050 |
Why?
|
Tumor Cells, Cultured | 2 | 2021 | 6129 | 0.050 |
Why?
|
France | 1 | 2023 | 497 | 0.050 |
Why?
|
Antigens, CD | 1 | 2013 | 4000 | 0.050 |
Why?
|
Gene Expression Profiling | 4 | 2017 | 9415 | 0.050 |
Why?
|
Models, Biological | 3 | 2009 | 9461 | 0.050 |
Why?
|
Gene Deletion | 3 | 2004 | 2667 | 0.050 |
Why?
|
Sequence Analysis, RNA | 2 | 2022 | 2019 | 0.050 |
Why?
|
Interferon Regulatory Factors | 1 | 2023 | 262 | 0.050 |
Why?
|
Time Factors | 2 | 2018 | 39928 | 0.050 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2024 | 691 | 0.050 |
Why?
|
Leukemia, Experimental | 2 | 2016 | 225 | 0.050 |
Why?
|
Carrier Proteins | 1 | 2014 | 4940 | 0.050 |
Why?
|
Child, Preschool | 4 | 2021 | 42204 | 0.050 |
Why?
|
Citric Acid Cycle | 1 | 2022 | 230 | 0.050 |
Why?
|
Transcription Factors | 1 | 2020 | 12113 | 0.040 |
Why?
|
Immunoblotting | 2 | 2014 | 1647 | 0.040 |
Why?
|
Disease Models, Animal | 4 | 2019 | 18218 | 0.040 |
Why?
|
Receptors, Fibronectin | 1 | 1999 | 37 | 0.040 |
Why?
|
Genetic Testing | 1 | 2012 | 3534 | 0.040 |
Why?
|
Piperazines | 2 | 2023 | 2519 | 0.040 |
Why?
|
Receptors, Vitronectin | 1 | 1999 | 47 | 0.040 |
Why?
|
Capillary Leak Syndrome | 1 | 2019 | 34 | 0.040 |
Why?
|
Mice, Transgenic | 4 | 2019 | 9532 | 0.040 |
Why?
|
Green Fluorescent Proteins | 1 | 2005 | 2059 | 0.040 |
Why?
|
HEK293 Cells | 2 | 2022 | 4273 | 0.040 |
Why?
|
Delayed Diagnosis | 1 | 2023 | 462 | 0.040 |
Why?
|
Transfection | 2 | 2005 | 5776 | 0.040 |
Why?
|
Registries | 1 | 2015 | 8213 | 0.040 |
Why?
|
Cohort Studies | 2 | 2019 | 41340 | 0.040 |
Why?
|
Tumor Microenvironment | 2 | 2024 | 3874 | 0.040 |
Why?
|
Cell Adhesion | 3 | 1999 | 3088 | 0.040 |
Why?
|
Prospective Studies | 1 | 2022 | 54304 | 0.040 |
Why?
|
Interferon-alpha | 1 | 2022 | 920 | 0.040 |
Why?
|
Microscopy, Fluorescence | 1 | 2005 | 2647 | 0.040 |
Why?
|
Benzamides | 1 | 2023 | 1370 | 0.040 |
Why?
|
Protein Array Analysis | 1 | 2019 | 401 | 0.040 |
Why?
|
Blotting, Western | 1 | 2005 | 5034 | 0.040 |
Why?
|
Membrane Proteins | 3 | 1999 | 7850 | 0.040 |
Why?
|
Monitoring, Immunologic | 1 | 2017 | 98 | 0.030 |
Why?
|
Antifungal Agents | 1 | 2022 | 751 | 0.030 |
Why?
|
Classification | 1 | 2017 | 127 | 0.030 |
Why?
|
Rwanda | 1 | 2019 | 665 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2022 | 1338 | 0.030 |
Why?
|
Patient Simulation | 1 | 2019 | 298 | 0.030 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1998 | 489 | 0.030 |
Why?
|
Cytoprotection | 1 | 2015 | 199 | 0.030 |
Why?
|
Ephrin-B1 | 3 | 1999 | 24 | 0.030 |
Why?
|
Chromosome Disorders | 1 | 2017 | 499 | 0.030 |
Why?
|
Isoquinolines | 1 | 2016 | 351 | 0.030 |
Why?
|
Protein Kinase C-alpha | 1 | 2014 | 113 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2014 | 14400 | 0.030 |
Why?
|
RNA Splicing | 1 | 2019 | 915 | 0.030 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 223 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2019 | 1871 | 0.030 |
Why?
|
Whole-Body Irradiation | 1 | 2015 | 433 | 0.030 |
Why?
|
Neoplasms, Experimental | 1 | 2019 | 1228 | 0.030 |
Why?
|
Retrospective Studies | 4 | 2022 | 80414 | 0.030 |
Why?
|
Oncogene Proteins | 1 | 1998 | 719 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2016 | 366 | 0.030 |
Why?
|
Genes, p53 | 1 | 2016 | 712 | 0.030 |
Why?
|
Transplantation, Homologous | 1 | 2022 | 4808 | 0.030 |
Why?
|
Melphalan | 1 | 2015 | 420 | 0.030 |
Why?
|
Killer Cells, Natural | 1 | 2022 | 2202 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 1998 | 1246 | 0.030 |
Why?
|
NIH 3T3 Cells | 1 | 2014 | 671 | 0.030 |
Why?
|
Cells, Cultured | 3 | 2017 | 18960 | 0.030 |
Why?
|
Genes, erbB-2 | 1 | 2012 | 162 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2016 | 2014 | 0.030 |
Why?
|
Antigens, CD34 | 2 | 2005 | 658 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2016 | 1824 | 0.020 |
Why?
|
RNA, Messenger | 2 | 2003 | 12787 | 0.020 |
Why?
|
Random Allocation | 1 | 2016 | 2388 | 0.020 |
Why?
|
Antigen Presentation | 1 | 2017 | 1254 | 0.020 |
Why?
|
Drug Synergism | 1 | 2015 | 1756 | 0.020 |
Why?
|
Receptors, Cytokine | 1 | 2012 | 258 | 0.020 |
Why?
|
Genes, Immunoglobulin | 1 | 2011 | 285 | 0.020 |
Why?
|
Pyrimidines | 1 | 2023 | 3024 | 0.020 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 1998 | 1624 | 0.020 |
Why?
|
Luciferases | 1 | 2012 | 714 | 0.020 |
Why?
|
Receptors, Notch | 1 | 2014 | 743 | 0.020 |
Why?
|
Recurrence | 1 | 2022 | 8466 | 0.020 |
Why?
|
Pedigree | 1 | 2017 | 4586 | 0.020 |
Why?
|
X-Ray Microtomography | 1 | 2012 | 450 | 0.020 |
Why?
|
Gene Dosage | 2 | 2004 | 1219 | 0.020 |
Why?
|
Body Height | 1 | 2015 | 1570 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2023 | 5789 | 0.020 |
Why?
|
Autoantibodies | 1 | 2017 | 2123 | 0.020 |
Why?
|
Remission Induction | 1 | 2014 | 2394 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 6472 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2017 | 2722 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2012 | 1696 | 0.020 |
Why?
|
Base Sequence | 1 | 2019 | 12440 | 0.020 |
Why?
|
Mutagenesis | 1 | 2012 | 1233 | 0.020 |
Why?
|
DNA Primers | 1 | 2012 | 2816 | 0.020 |
Why?
|
Biopsy | 1 | 2019 | 6765 | 0.020 |
Why?
|
Forkhead Transcription Factors | 1 | 2014 | 1611 | 0.020 |
Why?
|
Living Donors | 1 | 2011 | 639 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2017 | 4285 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39067 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2015 | 4848 | 0.020 |
Why?
|
Gene Frequency | 1 | 2013 | 3638 | 0.020 |
Why?
|
Disease Progression | 2 | 2019 | 13483 | 0.020 |
Why?
|
Infant | 2 | 2021 | 36179 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 2011 | 4171 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2017 | 5491 | 0.020 |
Why?
|
Quinazolines | 1 | 2012 | 1371 | 0.020 |
Why?
|
Translocation, Genetic | 1 | 2011 | 1387 | 0.020 |
Why?
|
Proteome | 1 | 2016 | 1861 | 0.020 |
Why?
|
RNA Interference | 1 | 2014 | 2834 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2013 | 4108 | 0.020 |
Why?
|
Risk Factors | 1 | 2012 | 73999 | 0.010 |
Why?
|
Body Weight | 1 | 2015 | 4609 | 0.010 |
Why?
|
Genotype | 1 | 2019 | 12971 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2014 | 2872 | 0.010 |
Why?
|
Crosses, Genetic | 1 | 2005 | 751 | 0.010 |
Why?
|
Fibronectins | 2 | 1998 | 722 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2014 | 6812 | 0.010 |
Why?
|
Cathepsin G | 1 | 2003 | 31 | 0.010 |
Why?
|
Tyrosine | 2 | 1998 | 1438 | 0.010 |
Why?
|
MicroRNAs | 1 | 2019 | 3796 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2014 | 3446 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2012 | 6206 | 0.010 |
Why?
|
Chromosomes, Mammalian | 1 | 2003 | 147 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2012 | 3429 | 0.010 |
Why?
|
Mutation, Missense | 1 | 2012 | 2571 | 0.010 |
Why?
|
Cathepsins | 1 | 2003 | 241 | 0.010 |
Why?
|
Protein Binding | 1 | 2014 | 9339 | 0.010 |
Why?
|
Graft vs Host Disease | 1 | 2014 | 3028 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2012 | 5865 | 0.010 |
Why?
|
Incidence | 1 | 2019 | 21308 | 0.010 |
Why?
|
Survival Rate | 1 | 2014 | 12697 | 0.010 |
Why?
|
Mice, SCID | 1 | 2005 | 2627 | 0.010 |
Why?
|
Research Design | 1 | 2016 | 6165 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 10174 | 0.010 |
Why?
|
Teratocarcinoma | 1 | 1998 | 16 | 0.010 |
Why?
|
Recombination, Genetic | 1 | 2003 | 1526 | 0.010 |
Why?
|
Receptor, EphB2 | 1 | 1998 | 26 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2012 | 11073 | 0.010 |
Why?
|
Serine Endopeptidases | 1 | 2003 | 1021 | 0.010 |
Why?
|
Arsenic | 1 | 2001 | 358 | 0.010 |
Why?
|
Genetic Variation | 1 | 2012 | 6570 | 0.010 |
Why?
|
Chromosome Deletion | 1 | 2001 | 1387 | 0.010 |
Why?
|
Dimerization | 1 | 1998 | 888 | 0.010 |
Why?
|
Surface Properties | 1 | 1999 | 1159 | 0.010 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 1998 | 441 | 0.010 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 1998 | 280 | 0.010 |
Why?
|
COS Cells | 1 | 1998 | 1128 | 0.010 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 1998 | 457 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 1998 | 1693 | 0.010 |
Why?
|
Enzyme Activation | 1 | 1998 | 3593 | 0.010 |
Why?
|
Ligands | 1 | 1998 | 3269 | 0.010 |
Why?
|
Drosophila Proteins | 1 | 1998 | 1698 | 0.000 |
Why?
|
Recombinant Proteins | 1 | 1998 | 6526 | 0.000 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 1998 | 2898 | 0.000 |
Why?
|
Endothelium, Vascular | 1 | 1998 | 4429 | 0.000 |
Why?
|
Nerve Tissue Proteins | 1 | 1998 | 4413 | 0.000 |
Why?
|